A few days after passing out during a gig, Gigi de Lana revealed she's dealing with pericarditis. According to the singer, ...

Gigi de Lana revealed that she has been diagnosed with pericarditis, days after she collapsed at a gig in Samal, Davao del Norte. De Lana addressed the fainting incident during a recent Facebook Live ...

Investing.com - Canaccord Genuity initiated coverage on Kiniksa Pharmaceuticals Inc. (NASDAQ:KNSA) with a buy rating and a price target of $62.00, representing potential upside from the current price ...

Cardiol Therapeutics (NASDAQ:CRDL) used a presentation at TD Cowen’s 46th Annual Healthcare Conference to outline its ...

Carly Pearce had been open about her frightening battle with pericarditis, and she is once again sounding the alarm for her ...

Physician adoption of ARCALYST as a second-line treatment was further supported by the 2025 ACC clinical guidance ...

Carly Pearce had been open about her frightening battle with pericarditis, and she is once again sounding the alarm for her ...

Sanj Patel, CEO, stated that "ARCALYST revenue continues to grow, driven by the expanding adoption of IL-1 alpha and beta inhibition across the recurrent pericarditis population." He highlighted a 65% ...

Analyst firm Canaccord Genuity initiated coverage on Kiniksa with a buy rating and set a price target of $62.00, recognizing the potential of its pericarditis treatment, Arcalyst. Additionally, TD ...

Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades.

Singer Gigi De Lana opened up about her condition and revealed that she has been diagnosed with pericarditis, days after she collapsed.